Preclinical Evaluation of In Vitro and In Vivo Antiviral Activities of KCT-01, a New Herbal Formula against Hepatitis B Virus

Hepatitis B virus (HBV) infectious diseases currently remain incurable due to limitations of conventional antivirals such as incapability of eradicating HBV DNA, prolonged use, drug resistance, and virological relapse. KCT-01, a 30% ethanol extract consisting of Artemisia capillaris, Sanguisorba off...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hong, Jang, Eungyeong, Kim, So-Young, Choi, Ji-Yoon, Lee, Na-Rae, Kim, Dae-Sung, Lee, Kyung-Tae, Inn, Kyung-Soo, Kim, Bum-Joon, Lee, Jang-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057320/
https://www.ncbi.nlm.nih.gov/pubmed/30069220
http://dx.doi.org/10.1155/2018/1073509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057320/
https://www.ncbi.nlm.nih.gov/pubmed/30069220
http://dx.doi.org/10.1155/2018/1073509

Ejemplares similares